← Leaderboards
James C Sacchettini
Univ Of North Carolina Chapel Hill
$23,620,665
Attributed
$52,320,473
Total exposure
23
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.2M · FY2005–24$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$98,034,399 · 28
By mechanism
P01$55,653,078 · 13
U19$30,000,379 · 6
U01$9,163,766 · 2
R01$2,879,640 · 2
U41$260,596 · 2
P41$60,940 · 2
Top collaborators
- Darrell P Chandler31 shared
- Aedin C Culhane31 shared
- Molly Forrest Franke31 shared
- Jerome Timothy Galea31 shared
- Anne Goldfeld31 shared
- Louise Catherine Ivers31 shared
- Ann Chesney Miller31 shared
- Nira Pollock31 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Ned Porter$13,848,998
- John E Sondek$15,232,788
- Nobuyo Maeda$24,013,018
- Beverly H Koller$30,354,187
- Craig E. Cameron$40,640,525
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisBaseStructureProgramsTuberculosisCellsProteinsLeadPharmaceutical PreparationsDrug ResistanceResourcesGeneticDiagnosisInnovationDiagnosticInhibitor/AntagonistEnzymesMycobacterialBiochemicalBiologyDiagnostic TestsDesignInfectionTuberculosis Drugs
Grant awards (114)
A novel protein export chaperone of Mycobacterium tuberculosis$508,167
R01 · FY2024 · AI
Core B. Biochemistry and Enzymology$138,926
P01 · FY2024 · AI · contact PI
A novel protein export chaperone of Mycobacterium tuberculosis$503,960
R01 · FY2023 · AI
Core B. Biochemistry and Enzymology$135,614
P01 · FY2023 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria$2,387,567
P01 · FY2022 · AI · contact PI
A novel protein export chaperone of Mycobacterium tuberculosis$521,036
R01 · FY2022 · AI
Project 2 - TB Translation as a Target$500,564
P01 · FY2022 · AI · contact PI
Core B. Biochemistry and Enzymology$132,403
P01 · FY2022 · AI · contact PI
Admin Core TAMU (Sacchettini) Lead$108,557
P01 · FY2022 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria$2,407,325
P01 · FY2021 · AI · contact PI
A novel protein export chaperone of Mycobacterium tuberculosis$573,838
R01 · FY2021 · AI
Project 2 - TB Translation as a Target$502,618
P01 · FY2021 · AI · contact PI
Core B. Biochemistry and Enzymology$129,279
P01 · FY2021 · AI · contact PI
Admin Core TAMU (Sacchettini) Lead$109,044
P01 · FY2021 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria$2,428,649
P01 · FY2020 · AI · contact PI
A novel protein export chaperone of Mycobacterium tuberculosis$598,742
R01 · FY2020 · AI
Project 2 - TB Translation as a Target$504,514
P01 · FY2020 · AI · contact PI
Core B. Biochemistry and Enzymology$144,539
P01 · FY2020 · AI · contact PI
Admin Core TAMU (Sacchettini) Lead$114,373
P01 · FY2020 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria$2,445,337
P01 · FY2019 · AI · contact PI
Project 2 - TB Translation as a Target$507,005
P01 · FY2019 · AI · contact PI
Admin Core TAMU (Sacchettini) Lead$107,735
P01 · FY2019 · AI · contact PI
Sequencing Core$2,595,356
U19 · FY2018 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria$2,542,664
P01 · FY2018 · AI · contact PI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$1,274,314
U19 · FY2018 · AI
Discovery and validation of drug resistance mutations$938,261
U19 · FY2018 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$888,730
U19 · FY2018 · AI
Project 2 - TB Translation as a Target$447,069
P01 · FY2018 · AI · contact PI
Administrative Core$412,046
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$403,448
U19 · FY2018 · AI
Admin Core TAMU (Sacchettini) Lead$103,240
P01 · FY2018 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,182,203
U19 · FY2017 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$1,095,803
U19 · FY2017 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$913,253
U19 · FY2017 · AI
Discovery and validation of drug resistance mutations$734,112
U19 · FY2017 · AI
Administrative Core$616,131
U19 · FY2017 · AI
Sequencing Core$408,777
U19 · FY2017 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,528,705
U19 · FY2016 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$992,134
U19 · FY2016 · AI
Discovery and validation of drug resistance mutations$750,894
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$715,308
U19 · FY2016 · AI
Sequencing Core$421,675
U19 · FY2016 · AI · contact PI
Administrative Core$410,524
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$82,633
U19 · FY2016 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,500,809
U19 · FY2015 · AI
Structure-based Discovery of Critical Vulnerabilities of Micobacteria$1,915,116
P01 · FY2015 · AI · contact PI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$932,090
U19 · FY2015 · AI
Discovery and validation of drug resistance mutations$774,241
U19 · FY2015 · AI
Sequencing Core$660,525
U19 · FY2015 · AI · contact PI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$500,331
U19 · FY2015 · AI
Structural Analysis of Metabolic Enzymes & Inhibitor Complexes in M. tubercul.$482,550
P01 · FY2015 · AI · contact PI
Administrative Core$311,434
U19 · FY2015 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,916,905
U19 · FY2014 · AI
Structure-based Discovery of Critical Vulnerabilities of Micobacteria$1,915,116
P01 · FY2014 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$1,190,346
U01 · FY2014 · GM · contact PI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$900,727
U19 · FY2014 · AI
Sequencing Core$822,385
U19 · FY2014 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$621,467
U01 · FY2014 · GM · contact PI
Discovery and validation of drug resistance mutations$554,926
U19 · FY2014 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$536,059
U19 · FY2014 · AI
Structural Analysis of Metabolic Enzymes & Inhibitor Complexes in M. tubercul.$469,528
P01 · FY2014 · AI · contact PI
Administrative Core$225,640
U19 · FY2014 · AI
Structure-based Discovery of Critical Vulnerabilities of Micobacteria$1,799,530
P01 · FY2013 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$1,150,586
U01 · FY2013 · GM · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$600,715
U01 · FY2013 · GM · contact PI
Structural Analysis of Metabolic Enzymes & Inhibitor Complexes in M. tubercul.$465,355
P01 · FY2013 · AI · contact PI
Structure-based Discovery of Critical Vulnerabilities of Micobacteria$1,973,398
P01 · FY2012 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$1,194,113
U01 · FY2012 · GM · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$659,945
U01 · FY2012 · GM · contact PI
Structural Analysis of Metabolic Enzymes & Inhibitor Complexes in M. tubercul.$490,116
P01 · FY2012 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$1,195,859
U01 · FY2011 · GM · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$624,230
U01 · FY2011 · GM · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$2,712,827
P01 · FY2010 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$1,265,173
U01 · FY2010 · GM · contact PI
The Cloning Protein Production, Crystallization, and X-ray Data Collection Core$931,833
P01 · FY2010 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$802,602
P01 · FY2010 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$661,332
U01 · FY2010 · GM · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$2,664,560
P01 · FY2009 · AI · contact PI
The Cloning Protein Production, Crystallization, and X-ray Data Collection Core$916,735
P01 · FY2009 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$787,755
P01 · FY2009 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$2,591,314
P01 · FY2008 · AI · contact PI
The Cloning Protein Production, Crystallization, and X-ray Data Collection Core$890,945
P01 · FY2008 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$764,514
P01 · FY2008 · AI · contact PI
Novel Drug Discovery against P. falciparum ENR$744,131
P01 · FY2008 · AI · contact PI
LEADS THAT TARGET P. FALCIPARUM ENR$322,454
P01 · FY2008 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$2,567,903
P01 · FY2007 · AI · contact PI
The Cloning Protein Production, Crystallization, and X-ray Data Collection Core$886,638
P01 · FY2007 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$758,592
P01 · FY2007 · AI · contact PI
Novel Drug Discovery against P. falciparum ENR$758,543
P01 · FY2007 · AI · contact PI
LEADS THAT TARGET P. FALCIPARUM ENR$328,703
P01 · FY2007 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$2,650,000
P01 · FY2006 · AI · contact PI
The Cloning Protein Production, Crystallization, and X-ray Data Collection Core$907,237
P01 · FY2006 · AI · contact PI
Novel Drug Discovery against P. falciparum ENR$781,198
P01 · FY2006 · AI · contact PI
Structural Genomics of Persistence Targets from M. tuberculosis$778,601
P01 · FY2006 · AI · contact PI
LEADS THAT TARGET P. FALCIPARUM ENR$346,669
P01 · FY2006 · AI · contact PI
Novel Drug Discovery against P. falciparum ENR$799,998
P01 · FY2005 · AI
LEADS THAT TARGET P. FALCIPARUM ENR$346,669
P01 · FY2005 · AI
NEW DRUG TARGETS FOR INFECTIOUS AGENTS$20,268
P41 · FY2005 · RR
2005 Tuberculosis Drug Development Gordon Conference$16,000
R13 · FY2005 · AI
Novel Drug Discovery against P. falciparum ENR$799,236
P01 · FY2004 · AI
LEADS THAT TARGET P. FALCIPARUM ENR$346,339
P01 · FY2004 · AI
STRUCTURE DETERMINATION OF DRUG TARGETS FROM MICROBIAL PATHOGENS$40,672
P41 · FY2004 · RR
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS$876,066
P01 · FY2003 · AI
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS$610,194
P01 · FY2002 · AI
Persistent TB drug discovery$0
P01 · FY2002 · AI
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS$684,119
P01 · FY2001 · AI
STRUCT OF DRUG TARGETS FROM MICROBIAL PATHOGENS: TB, LYME, STAPH$120,630
U41 · FY2001 · RR
STRUCT OF DRUG TARGETS FROM MICROBIAL PATHOGENS: TB, LYME, STAPH$120,630
U41 · FY2001 · RR
Persistent TB drug discovery$0
P01 · FY2001 · AI
DRUG DISCOVERY FOR PERSISTENT TUBERCULOSIS$663,058
P01 · FY2000 · AI
Persistent TB drug discovery$225,914
P01 · FY2000 · AI
X-RAY CRYSTALLOGRAPHY ON PROTEINS OF CELLULAR IMMUNITY$173,897
R01 · FY2000 · AI
STRUCT OF DRUG TARGETS FROM MICROBIAL PATHOGENS: TB, LYME, STAPH$12,475
U41 · FY2000 · RR
STRUCT OF DRUG TARGETS FROM MICROBIAL PATHOGENS: TB, LYME, STAPH$6,861
U41 · FY2000 · RR